 | • レポートコード：MRC2312MG13583 • 出版社/出版日：Market Monitor Global / 2023年12月 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥487,500 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥731,250 (USD4,875) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査レポートは次の情報を含め、世界の肝臓がんスクリーニング装置市場規模と予測を収録しています。・世界の肝臓がんスクリーニング装置市場：売上、2018年-2023年、2024年-2029年 ・世界の肝臓がんスクリーニング装置市場：販売量、2018年-2023年、2024年-2029年 ・世界のトップ5企業、2022年 世界の肝臓がんスクリーニング装置市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「血液検査」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。 肝臓がんスクリーニング装置のグローバル主要企業は、Abbott Laboratories、 Thermo Fisher Scientific, Inc.、 Berry Oncology、 New Horizon Health、 BGI、 GTH.O、 Livzon、 BNR.O、 SingLera、 Fujifilm Medical Systems U.S.A., Inc.、 F. Hoffmann-La Roche Ltd.、 Siemens Healthineers、 BD、 Illumina, Inc.、 Epigenomics AGなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。 MARKET MONITOR GLOBAL（MMG）は、肝臓がんスクリーニング装置のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の肝臓がんスクリーニング装置市場：タイプ別、2018年-2023年、2024年-2029年 世界の肝臓がんスクリーニング装置市場：タイプ別市場シェア、2022年 ・血液検査、画像検査 世界の肝臓がんスクリーニング装置市場：用途別、2018年-2023年、2024年-2029年 世界の肝臓がんスクリーニング装置市場：用途別市場シェア、2022年 ・病院、診療所、その他 世界の肝臓がんスクリーニング装置市場：地域・国別、2018年-2023年、2024年-2029年 世界の肝臓がんスクリーニング装置市場：地域別市場シェア、2022年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における肝臓がんスクリーニング装置のグローバル売上、2018年-2023年 ・主要企業における肝臓がんスクリーニング装置のグローバル売上シェア、2022年 ・主要企業における肝臓がんスクリーニング装置のグローバル販売量、2018年-2023年 ・主要企業における肝臓がんスクリーニング装置のグローバル販売量シェア、2022年 さらに、当レポートは主要企業のプロファイルを提示します。 Abbott Laboratories、 Thermo Fisher Scientific, Inc.、 Berry Oncology、 New Horizon Health、 BGI、 GTH.O、 Livzon、 BNR.O、 SingLera、 Fujifilm Medical Systems U.S.A., Inc.、 F. Hoffmann-La Roche Ltd.、 Siemens Healthineers、 BD、 Illumina, Inc.、 Epigenomics AG ************************************************************* ・調査・分析レポートの概要 肝臓がんスクリーニング装置市場の定義 市場セグメント 世界の肝臓がんスクリーニング装置市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の肝臓がんスクリーニング装置市場規模 世界の肝臓がんスクリーニング装置市場規模：2022年 VS 2029年 世界の肝臓がんスクリーニング装置市場規模と予測 2018年-2029年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの肝臓がんスクリーニング装置の売上 グローバルトップ3およびトップ5企業、2022年売上ベース グローバル企業の肝臓がんスクリーニング装置製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：血液検査、画像検査 肝臓がんスクリーニング装置のタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：病院、診療所、その他 肝臓がんスクリーニング装置の用途別グローバル売上・予測 ・地域別市場分析 地域別肝臓がんスクリーニング装置市場規模 2022年と2029年 地域別肝臓がんスクリーニング装置売上・予測 北米市場：アメリカ、カナダ、メキシコ ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア アジア市場：中国、日本、韓国、東南アジア、インド 南米市場：ブラジル、アルゼンチン 中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Abbott Laboratories、 Thermo Fisher Scientific, Inc.、 Berry Oncology、 New Horizon Health、 BGI、 GTH.O、 Livzon、 BNR.O、 SingLera、 Fujifilm Medical Systems U.S.A., Inc.、 F. Hoffmann-La Roche Ltd.、 Siemens Healthineers、 BD、 Illumina, Inc.、 Epigenomics AG ... |
This research report provides a comprehensive analysis of the Screening for Liver Cancer market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Screening for Liver Cancer market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Screening for Liver Cancer, challenges faced by the industry, and potential opportunities for market players.
The global Screening for Liver Cancer market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Screening for Liver Cancer market presents opportunities for various stakeholders, including Hospital, Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Screening for Liver Cancer market. Additionally, the growing consumer demand present avenues for market expansion.
The global Screening for Liver Cancer market was valued at US$ 8221.7 million in 2022 and is projected to reach US$ 13660 million by 2029, at a CAGR of 7.6% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Globally, liver cancer is one of the leading causes of cancer-related deaths. According to the American Cancer Society, the incidence of liver cancer has tripled since the 1980s, and the death rate has now doubled. In the United States, about 41,260 new cases are expected to be diagnosed, while about 30,520 deaths from liver cancer are expected, according to 2022 cancer statistics. The global prevalence of liver cancer and the continuous exposure of related populations to risk factors will rapidly drive the screening and diagnostics market.
Key Features:
The research report on the Screening for Liver Cancer market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Screening for Liver Cancer market.
Market Overview: The report provides a comprehensive overview of the Screening for Liver Cancer market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Hematology Test, Imaging Test), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Screening for Liver Cancer market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Screening for Liver Cancer market’s trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Screening for Liver Cancer market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Screening for Liver Cancer market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Screening for Liver Cancer market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Screening for Liver Cancer market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Screening for Liver Cancer, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Screening for Liver Cancer market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Screening for Liver Cancer market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Hematology Test
Imaging Test
Market segment by Application
Hospital
Clinic
Other
Global Screening for Liver Cancer Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Abbott Laboratories
Thermo Fisher Scientific, Inc.
Berry Oncology
New Horizon Health
BGI
GTH.O
Livzon
BNR.O
SingLera
Fujifilm Medical Systems U.S.A., Inc.
F. Hoffmann-La Roche Ltd.
Siemens Healthineers
BD
Illumina, Inc.
Epigenomics AG
Outline of Major Chapters:
Chapter 1: Introduces the definition of Screening for Liver Cancer, market overview.
Chapter 2: Global Screening for Liver Cancer market size in revenue.
Chapter 3: Detailed analysis of Screening for Liver Cancer company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Screening for Liver Cancer in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Screening for Liver Cancer Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Screening for Liver Cancer Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Screening for Liver Cancer Overall Market Size
2.1 Global Screening for Liver Cancer Market Size: 2022 VS 2029
2.2 Global Screening for Liver Cancer Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Screening for Liver Cancer Players in Global Market
3.2 Top Global Screening for Liver Cancer Companies Ranked by Revenue
3.3 Global Screening for Liver Cancer Revenue by Companies
3.4 Top 3 and Top 5 Screening for Liver Cancer Companies in Global Market, by Revenue in 2022
3.5 Global Companies Screening for Liver Cancer Product Type
3.6 Tier 1, Tier 2 and Tier 3 Screening for Liver Cancer Players in Global Market
3.6.1 List of Global Tier 1 Screening for Liver Cancer Companies
3.6.2 List of Global Tier 2 and Tier 3 Screening for Liver Cancer Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type – Global Screening for Liver Cancer Market Size Markets, 2022 & 2029
4.1.2 Hematology Test
4.1.3 Imaging Test
4.2 By Type – Global Screening for Liver Cancer Revenue & Forecasts
4.2.1 By Type – Global Screening for Liver Cancer Revenue, 2018-2023
4.2.2 By Type – Global Screening for Liver Cancer Revenue, 2024-2029
4.2.3 By Type – Global Screening for Liver Cancer Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Screening for Liver Cancer Market Size, 2022 & 2029
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application – Global Screening for Liver Cancer Revenue & Forecasts
5.2.1 By Application – Global Screening for Liver Cancer Revenue, 2018-2023
5.2.2 By Application – Global Screening for Liver Cancer Revenue, 2024-2029
5.2.3 By Application – Global Screening for Liver Cancer Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region – Global Screening for Liver Cancer Market Size, 2022 & 2029
6.2 By Region – Global Screening for Liver Cancer Revenue & Forecasts
6.2.1 By Region – Global Screening for Liver Cancer Revenue, 2018-2023
6.2.2 By Region – Global Screening for Liver Cancer Revenue, 2024-2029
6.2.3 By Region – Global Screening for Liver Cancer Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country – North America Screening for Liver Cancer Revenue, 2018-2029
6.3.2 US Screening for Liver Cancer Market Size, 2018-2029
6.3.3 Canada Screening for Liver Cancer Market Size, 2018-2029
6.3.4 Mexico Screening for Liver Cancer Market Size, 2018-2029
6.4 Europe
6.4.1 By Country – Europe Screening for Liver Cancer Revenue, 2018-2029
6.4.2 Germany Screening for Liver Cancer Market Size, 2018-2029
6.4.3 France Screening for Liver Cancer Market Size, 2018-2029
6.4.4 U.K. Screening for Liver Cancer Market Size, 2018-2029
6.4.5 Italy Screening for Liver Cancer Market Size, 2018-2029
6.4.6 Russia Screening for Liver Cancer Market Size, 2018-2029
6.4.7 Nordic Countries Screening for Liver Cancer Market Size, 2018-2029
6.4.8 Benelux Screening for Liver Cancer Market Size, 2018-2029
6.5 Asia
6.5.1 By Region – Asia Screening for Liver Cancer Revenue, 2018-2029
6.5.2 China Screening for Liver Cancer Market Size, 2018-2029
6.5.3 Japan Screening for Liver Cancer Market Size, 2018-2029
6.5.4 South Korea Screening for Liver Cancer Market Size, 2018-2029
6.5.5 Southeast Asia Screening for Liver Cancer Market Size, 2018-2029
6.5.6 India Screening for Liver Cancer Market Size, 2018-2029
6.6 South America
6.6.1 By Country – South America Screening for Liver Cancer Revenue, 2018-2029
6.6.2 Brazil Screening for Liver Cancer Market Size, 2018-2029
6.6.3 Argentina Screening for Liver Cancer Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Screening for Liver Cancer Revenue, 2018-2029
6.7.2 Turkey Screening for Liver Cancer Market Size, 2018-2029
6.7.3 Israel Screening for Liver Cancer Market Size, 2018-2029
6.7.4 Saudi Arabia Screening for Liver Cancer Market Size, 2018-2029
6.7.5 UAE Screening for Liver Cancer Market Size, 2018-2029
7 Screening for Liver Cancer Companies Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Screening for Liver Cancer Major Product Offerings
7.1.4 Abbott Laboratories Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 Thermo Fisher Scientific, Inc.
7.2.1 Thermo Fisher Scientific, Inc. Company Summary
7.2.2 Thermo Fisher Scientific, Inc. Business Overview
7.2.3 Thermo Fisher Scientific, Inc. Screening for Liver Cancer Major Product Offerings
7.2.4 Thermo Fisher Scientific, Inc. Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.2.5 Thermo Fisher Scientific, Inc. Key News & Latest Developments
7.3 Berry Oncology
7.3.1 Berry Oncology Company Summary
7.3.2 Berry Oncology Business Overview
7.3.3 Berry Oncology Screening for Liver Cancer Major Product Offerings
7.3.4 Berry Oncology Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.3.5 Berry Oncology Key News & Latest Developments
7.4 New Horizon Health
7.4.1 New Horizon Health Company Summary
7.4.2 New Horizon Health Business Overview
7.4.3 New Horizon Health Screening for Liver Cancer Major Product Offerings
7.4.4 New Horizon Health Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.4.5 New Horizon Health Key News & Latest Developments
7.5 BGI
7.5.1 BGI Company Summary
7.5.2 BGI Business Overview
7.5.3 BGI Screening for Liver Cancer Major Product Offerings
7.5.4 BGI Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.5.5 BGI Key News & Latest Developments
7.6 GTH.O
7.6.1 GTH.O Company Summary
7.6.2 GTH.O Business Overview
7.6.3 GTH.O Screening for Liver Cancer Major Product Offerings
7.6.4 GTH.O Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.6.5 GTH.O Key News & Latest Developments
7.7 Livzon
7.7.1 Livzon Company Summary
7.7.2 Livzon Business Overview
7.7.3 Livzon Screening for Liver Cancer Major Product Offerings
7.7.4 Livzon Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.7.5 Livzon Key News & Latest Developments
7.8 BNR.O
7.8.1 BNR.O Company Summary
7.8.2 BNR.O Business Overview
7.8.3 BNR.O Screening for Liver Cancer Major Product Offerings
7.8.4 BNR.O Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.8.5 BNR.O Key News & Latest Developments
7.9 SingLera
7.9.1 SingLera Company Summary
7.9.2 SingLera Business Overview
7.9.3 SingLera Screening for Liver Cancer Major Product Offerings
7.9.4 SingLera Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.9.5 SingLera Key News & Latest Developments
7.10 Fujifilm Medical Systems U.S.A., Inc.
7.10.1 Fujifilm Medical Systems U.S.A., Inc. Company Summary
7.10.2 Fujifilm Medical Systems U.S.A., Inc. Business Overview
7.10.3 Fujifilm Medical Systems U.S.A., Inc. Screening for Liver Cancer Major Product Offerings
7.10.4 Fujifilm Medical Systems U.S.A., Inc. Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.10.5 Fujifilm Medical Systems U.S.A., Inc. Key News & Latest Developments
7.11 F. Hoffmann-La Roche Ltd.
7.11.1 F. Hoffmann-La Roche Ltd. Company Summary
7.11.2 F. Hoffmann-La Roche Ltd. Business Overview
7.11.3 F. Hoffmann-La Roche Ltd. Screening for Liver Cancer Major Product Offerings
7.11.4 F. Hoffmann-La Roche Ltd. Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.11.5 F. Hoffmann-La Roche Ltd. Key News & Latest Developments
7.12 Siemens Healthineers
7.12.1 Siemens Healthineers Company Summary
7.12.2 Siemens Healthineers Business Overview
7.12.3 Siemens Healthineers Screening for Liver Cancer Major Product Offerings
7.12.4 Siemens Healthineers Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.12.5 Siemens Healthineers Key News & Latest Developments
7.13 BD
7.13.1 BD Company Summary
7.13.2 BD Business Overview
7.13.3 BD Screening for Liver Cancer Major Product Offerings
7.13.4 BD Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.13.5 BD Key News & Latest Developments
7.14 Illumina, Inc.
7.14.1 Illumina, Inc. Company Summary
7.14.2 Illumina, Inc. Business Overview
7.14.3 Illumina, Inc. Screening for Liver Cancer Major Product Offerings
7.14.4 Illumina, Inc. Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.14.5 Illumina, Inc. Key News & Latest Developments
7.15 Epigenomics AG
7.15.1 Epigenomics AG Company Summary
7.15.2 Epigenomics AG Business Overview
7.15.3 Epigenomics AG Screening for Liver Cancer Major Product Offerings
7.15.4 Epigenomics AG Screening for Liver Cancer Revenue in Global Market (2018-2023)
7.15.5 Epigenomics AG Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
